LINCOLNLincoln Pharmaceuticals Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹597.40
▲ 0.07%Weak
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,215.70
P/E13.94
P/B1.60
PEG23.24
ROE %12.30
ROCE %10.90
Debt / Equity0.01
EPS43.53
Revenue Growth %11.40
Profit Growth %0.60
Dividend Yield %0.30
Promoter Holding %56.11
FII Holding %1.07
DII Holding %—
Beta0.37
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Double Top | SHORT | 60% | ₹597.40 | ₹657.00 | ₹547.00 | 0.85 |
AVOIDConviction 69%
Why avoid
- • A bearish pattern is active and overall evidence is mixed
- • Profit growth: 0.6% YoY
- • ROCE: 10.9%
- • RSI: 40
- • MACD: bearish
- • Double Top bearish signal (setup quality 60%)
Bull case
- • Debt/Equity: 0.01
- • Promoter holding: 56.1%
- • Valuation vs sector: P/E 13.9 vs sector 38.6
- • Price vs SMA200: above
Bear case
- • Profit growth: 0.6% YoY
- • ROCE: 10.9%
- • RSI: 40
- • MACD: bearish
Key risks
- • Profit growth: 0.6% YoY
- • ROCE: 10.9%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹597.40
Stop Loss
₹582.86
risk 2.4%
Target 1 (1.5R)
₹619.21
+3.7%
Target 2 (3R)
₹641.01
+7.3%
Support (20d)
₹588.75
Resistance (52w)
₹770.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹14.54/share
ATR (volatility)
₹17.95
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹17.95). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
48
Technical
33
Momentum
50
Risk (safety)
51